The European Medicines Agency recommended the approval of Novo Nordisk’s Wegovy weight-loss pill Friday, paving the way for it to become the first tablet to treat obesity in the bloc.
The once-daily Wegovy pill launched in the U.S. in early January and has seen strong uptake among Americans, with executives announcing earlier this month that over 1 million patients are taking the drug.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8